Insider Ledger
Toast, Inc. (TOST) insider buying and SEC filings
Toast, Inc. · CIK 1650164
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Services-Computer Processing & Data Preparation
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$5.4M
Planned sales (10b5-1)
$23.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 2, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 14,280 shares at about $33.70 ($481K), marked as a 10b5-1 plan trade. Holdings down 16% to 77,424 shares. | SEC filing Filed Nov 4, 2026, 4:35 PM ET |
| Nov 3, 2026 | Sale | Rossana Niola (Principal Accounting Officer) sold 1,128 shares at $33.46 ($38K). Holdings down 15% to 6,480 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 4, 2026, 4:34 PM ET |
| Oct 5, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 7,623 shares at about $30.19 ($230K), marked as a 10b5-1 plan trade. Holdings down 9% to 77,424 shares. | SEC filing Filed Oct 6, 2026, 4:50 PM ET |
| Oct 2, 2026 | Sale | Elena Gomez (CFO) sold 11,886 shares at $29.35 ($349K). Holdings down 6% to 171,957 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 5, 2026, 4:34 PM ET |
| Oct 2, 2026 | Sale | Stephen Fredette (President / COO and Director) sold 9,368 shares at $29.35 ($275K). Holdings down 1% to 941,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 5, 2026, 4:34 PM ET |
| Oct 2, 2026 | Sale | Aman Narang (CEO and Director) sold 14,713 shares at $29.35 ($432K). Holdings down 15% to 86,543 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 5, 2026, 4:32 PM ET |
| Oct 2, 2026 | Sale | Brian R Elworthy (General Counsel) sold 6,507 shares at $29.35 ($191K). Holdings down 3% to 204,023 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 5, 2026, 4:32 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 13,465 shares at about $29.69 ($400K), marked as a 10b5-1 plan trade. Holdings down 15% to 77,424 shares. | SEC filing Filed Oct 5, 2026, 4:31 PM ET |
| Sep 2, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 14,280 shares at about $33.90 ($484K), marked as a 10b5-1 plan trade. Holdings down 17% to 69,966 shares. | SEC filing Filed Sep 4, 2026 |
| Aug 21, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 85,280 shares at about $36.34 ($3.1M), marked as a 10b5-1 plan trade. Holdings down 55% to 69,966 shares. | SEC filing Filed Aug 25, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 13,931 shares at about $36.01 ($502K), marked as a 10b5-1 plan trade. Holdings down 17% to 69,966 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 13,797 shares at about $36.01 ($497K), marked as a 10b5-1 plan trade. Holdings down 16% to 69,966 shares. | SEC filing Filed Aug 13, 2026 |
| Aug 7–10, 2026 | Planned (10b5-1) | Aman Narang (CEO and Director) sold 161,948 shares indirectly (by trust) between Aug 7 and Aug 10 at about $35.32 ($5.7M), marked as a 10b5-1 plan trade. Holdings by trust down 100% to 0 shares. | SEC filing Filed Aug 11, 2026 |
| Aug 7–10, 2026 | Planned (10b5-1) | Elena Gomez (CFO) sold 7,924 shares between Aug 7 and Aug 10 at about $35.30 ($280K), marked as a 10b5-1 plan trade. Holdings down 5% to 160,150 shares. | SEC filing Filed Aug 11, 2026 |
| Aug 5–6, 2026 | Planned (10b5-1) | Aman Narang (CEO and Director) sold 138,052 shares indirectly (by trust) between Aug 5 and Aug 6 at about $35.26 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 46% to 161,948 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 4,700 shares at about $36.02 ($169K), marked as a 10b5-1 plan trade. Holdings down 6% to 69,966 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 5–6, 2026 | Planned (10b5-1) | Elena Gomez (CFO) sold 17,076 shares between Aug 5 and Aug 6 at about $35.28 ($602K), marked as a 10b5-1 plan trade. Holdings down 9% to 168,074 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 4, 2026 | Sale | Rossana Niola (Principal Accounting Officer) sold 2,298 shares at $33.45 ($77K). Holdings down 35% to 4,306 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 14,280 shares at about $32.89 ($470K), marked as a 10b5-1 plan trade. Holdings down 17% to 69,966 shares. | SEC filing Filed Aug 4, 2026 |
| Jul 13–14, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 11,170 shares between Jul 13 and Jul 14 at about $30.16 ($337K), marked as a 10b5-1 plan trade. Holdings down 14% to 69,966 shares. | SEC filing Filed Jul 15, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 3,150 shares at about $30.03 ($95K), marked as a 10b5-1 plan trade. Holdings down 4% to 69,966 shares. | SEC filing Filed Jul 9, 2026 |
| Jul 2, 2026 | Sale | Jonathan Vassil (Chief Revenue Officer) sold 6,647 shares at $28.85 ($192K). Holdings down 9% to 69,966 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Sale | Aman Narang (CEO and Director) sold 14,365 shares at $28.85 ($414K). Holdings down 17% to 70,451 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Sale | Brian R Elworthy (General Counsel) sold 6,352 shares at $28.85 ($183K). Holdings down 3% to 196,909 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Sale | Stephen Fredette (President / COO and Director) sold 9,146 shares at $28.85 ($264K). Holdings down 1% to 931,449 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Sale | Elena Gomez (CFO) sold 11,605 shares at $28.85 ($335K). Holdings down 6% to 185,150 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| May 29, 2026 | Planned (10b5-1) | Brian R Elworthy (General Counsel) sold 108,000 shares at about $25.89 ($2.8M), marked as a 10b5-1 plan trade. Holdings down 36% to 189,642 shares. | SEC filing Filed Jun 2, 2026 |
| Jan 9, 2025 | Sale | Deval L. Patrick (Director) sold 1,667 shares at $36.95 ($62K). Holdings down 4% to 45,815 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 23, 2026 |
| Apr 2, 2026 | Sale | Jonathan Vassil (Chief Revenue Officer) sold 6,438 shares at $26.19 ($169K). Holdings down 4% to 146,618 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 3, 2026 |
| Apr 2, 2026 | Sale | Brian R Elworthy (General Counsel) sold 3,664 shares at $26.19 ($96K). Holdings down 1% to 243,642 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 3, 2026 |
| Apr 2, 2026 | Sale | Stephen Fredette (President / COO and Director) sold 7,289 shares at $26.19 ($191K). Holdings down 1% to 920,985 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 3, 2026 |
| Apr 2, 2026 | Sale | Elena Gomez (CFO) sold 8,929 shares at $26.19 ($234K). Holdings down 5% to 173,064 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 3, 2026 |
| Apr 2, 2026 | Sale | Aman Narang (CEO and Director) sold 13,463 shares at $26.19 ($353K). Holdings down 20% to 54,013 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 3, 2026 |
| Mar 12, 2026 | Sale | Susan Chapman-Hughes (Director) sold 8,500 shares at $28.97 ($246K). Holdings down 37% to 14,530 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Feb 3, 2026 | Sale | Jonathan Vassil (Chief Revenue Officer) sold 1,454 shares at $30.35 ($44K). Holdings down 1% to 139,893 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Sale | Aman Narang (CEO and Director) sold 1,648 shares at $30.35 ($50K). Holdings down <1% to 340,723 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Sale | Elena Gomez (CFO) sold 1,437 shares at $30.35 ($44K). Holdings down 1% to 164,629 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Sale | Stephen Fredette (President / COO and Director) sold 1,060 shares at $30.35 ($32K). Holdings down <1% to 913,067 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Feb 3, 2026 | Sale | Brian R Elworthy (General Counsel) sold 648 shares at $30.35 ($20K). Holdings down <1% to 237,261 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Jan 5, 2026 | Sale | Brian R Elworthy (General Counsel) sold 3,303 shares at $34.38 ($114K). Holdings down 1% to 235,757 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Sale | Stephen Fredette (President / COO and Director) sold 4,866 shares at $34.38 ($167K). Holdings down 1% to 910,606 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Sale | Elena Gomez (CFO) sold 6,672 shares at $34.38 ($229K). Holdings down 4% to 162,153 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Sale | Aman Narang (CEO and Director) sold 8,591 shares at $34.38 ($295K). Holdings down 2% to 338,850 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 4,787 shares at $34.38 ($165K), marked as a 10b5-1 plan trade. Holdings down 6% to 79,802 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Jonathan Vassil (Chief Revenue Officer) sold 66,390 shares at $35.86 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 44% to 84,589 shares. | SEC filing Filed Jan 5, 2026 |
| Nov 4, 2025 | Sale | Brian R Elworthy (General Counsel) sold 1,059 shares at $35.54 ($38K). Holdings down <1% to 229,017 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
| Nov 4, 2025 | Sale | Stephen Fredette (President / COO and Director) sold 1,732 shares at $35.54 ($62K). Holdings down <1% to 900,264 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
| Nov 4, 2025 | Sale | Elena Gomez (CFO) sold 2,021 shares at $35.54 ($72K). Holdings down 1% to 151,463 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
| Nov 4, 2025 | Sale | Aman Narang (CEO and Director) sold 1,732 shares at $35.54 ($62K). Holdings down 1% to 319,939 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
| Nov 4, 2025 | Sale | Jonathan Vassil (Chief Revenue Officer) sold 1,442 shares at $35.54 ($51K). Holdings down 2% to 71,424 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
59 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:12 PM ET 8-K | Earnings released (Item 2.02) Executive or director change (Item 5.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TOST in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.